HIV and Injectable Drugs
Year Developed: 2021
Resource Type: Archived Webinar.Primary Audience: Clinicians
Language(s): English
Developed by: National LGBTQIA+ Health Education Center at The Fenway Institute (See other resources developed by this organization).
Resource Summary: Long-acting injectable antiretrovirals are currently available for treatment of HIV, and approval for HIV prevention is anticipated soon; these developments may significantly change the landscape of HIV treatment and prevention. In this case-based webinar, Dr. Kevin Ard will discuss injectable antiretrovirals for HIV treatment and prevention. By the end of the webinar, participants will be familiar with the most up-to-date evidence for injectable antiretrovirals and will be able to describe programmatic changes that may be necessary to implement long-acting injectable medications in clinical practice.
Resource Topic: Clinical Issues, Emerging Issues, Special and Vulnerable Populations
Resource Subtopic: HIV/AIDS, Research and Data.
Keywords: Access to Care, LGBTQIA+, Prevention, Risk Management, Sexually Transmitted Infections (STIs).This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.